ovarian cancer

Protein Compels Ovarian Cancer Cells To Cannibalize Themselves

admin — Mon, 17 Nov 2008 23:15:04 -0600

A protein known to inhibit the growth of ovarian cancer works in part by forcing cancer cells to eat themselves until they die, researchers report in Cancer Research.

Vascular Marker Of Ovarian Cancer Identified

admin — Sun, 28 Sep 2008 20:00:09 -0500

Researchers have identified TEM1 as a specific genetic marker for the vascular cells associated with tumor growth, a finding that could aid in diagnosis and treatment of ovarian cancer.

Ovarian Cancer Drug Trial Reveals Promising New Treatment

admin — Mon, 15 Sep 2008 12:30:20 -0500

Women with recurrent ovarian cancer can be helped by an experimental therapy using a drug already touted for its ability to fight other cancers, a finding that provides hope for improved treatment of this deadly disease.

Drug Compound Leads To Death Of Ovarian Cancer Cells Resistant T...

admin — Mon, 21 Apr 2008 11:00:00 -0500

In a discovery that may be useful for maintaining remission in chemo-resistant ovarian cancer, Yale scientists report that pre-clinical studies have shown the drug compound NV-128 can induce the death of ovarian cancer cells by halting the activation of a protein pathway called mTOR.

Ovarian Cancer Stem Cells Identified, Characterized

admin — Fri, 18 Apr 2008 05:00:00 -0500

Researchers have identified, characterized and cloned ovarian cancer stem cells and have shown that these stem cells may be the source of ovarian cancer's recurrence and its resistance to chemotherapy.

Five Years Later, Patient On Vaccine Trial Still Free Of Ovarian...

admin — Mon, 07 Apr 2008 14:00:00 -0500

Like most women with ovarian cancer, 44-year-old Christine Sable of Lancaster, Pennsylvania, did not discover she had the disease until it was in the advanced stages and had spread to other areas of the abdomen. "I knew my chances of recurrence were very high--75 to 80 percent at that particular stage--and that the disease would likely recur within a year or two," she says. "Once it recurs, it is difficult to cure."

Clues To Prevent Spread Of Ovarian Cancer

admin — Tue, 18 Mar 2008 08:00:00 -0500

A drug that blocks production of an enzyme that enables ovarian cancer to gain a foothold in a new site can slow the spread of the disease and prolong survival in mice, but only if the drug is given early in the disease process.

Recurrent Low-grade Carcinoma Of The Ovary Less Responsive To Ch...

admin — Thu, 13 Mar 2008 02:00:00 -0500

Recurrent low-grade serous carcinoma, a rare type of ovarian cancer, is less sensitive to chemotherapy and therefore more difficult to treat than more common high-grade ovarian cancers, according to researchers.

Advanced-stage Ovarian Cancer Patients With BRCA Live Longer, Ma...

admin — Wed, 12 Mar 2008 08:00:00 -0500

Two abstracts underscoring the importance of testing for BRCA1/2 mutations in women with ovarian cancer have recently been presented. The majority of women with ovarian cancer are unaware BRCA testing is available.

Malignant tumor or benign cyst?

admin — Mon, 10 Mar 2008 00:00:00 -0500

The results of a study presented today at the Society of Gynecologic Oncology's 39th Annual Meeting on Women's Cancer offer a promising development on the path toward better management of ovarian cancer. Researchers say testing women suspected of having ovarian cancer for a combination of proteins, or biomarkers in the blood called HE4 and CA 125, could be the key to predicting a woman's risk for the disease dubbed the "silent killer." Currently there is no adequate diagnostic test for ovarian cancer.